| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00066-008-1829-Z |
| P698 | PubMed publication ID | 18259703 |
| P50 | author | Peter Arne Gerber | Q40367503 |
| P2093 | author name string | Guido Lammering | |
| Bernhard Homey | |||
| Wilfried Budach | |||
| Christiane Matuschek | |||
| Edwin Bölke | |||
| Thomas K Hoffmann | |||
| Matthias Peiper | |||
| Anja Müller-Homey | |||
| Stephan Gripp | |||
| Daniela Bruch-Gerharz | |||
| Christian Giro | |||
| Hildegard Pape | |||
| P433 | issue | 2 | |
| P921 | main subject | adaptive radiation therapy | Q180507 |
| cetuximab | Q420296 | ||
| P304 | page(s) | 105-110 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Strahlentherapie und Onkologie | Q15724604 |
| P1476 | title | Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab | |
| P478 | volume | 184 |
| Q39843033 | A Phase I/II Study of Altered Fractionated IMRT Alone for Intermediate T-Stage Oropharyngeal Carcinoma |
| Q33983656 | Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer |
| Q54350777 | Adverse skin reactions during treatment with cetuximab plus radiotherapy: Multidisciplinary approach to minimize radio-chemotherapy interruption. |
| Q37866779 | Cetuximab in the treatment of squamous cell carcinoma of the head and neck |
| Q36880604 | Cetuximab: its unique place in head and neck cancer treatment |
| Q84637878 | Chemoradiotherapy with weekly cisplatin 40 mg/m(2) in 103 head-and-neck cancer patients: a cumulative dose-effect analysis |
| Q83673199 | Combined-modality treatment in advanced oral squamous cell carcinoma: Primary surgery followed by adjuvant concomitant radiochemotherapy |
| Q87461014 | Concurrent use of cisplatin or cetuximab with definitive radiotherapy for locally advanced head and neck squamous cell carcinomas |
| Q53150085 | Cost effectiveness of cetuximab concurrent with radiotherapy for patients with locally advanced head and neck cancer in Taiwan: a decision-tree analysis. |
| Q51598157 | Cystatin C - a fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients. |
| Q54610714 | Density of Demodex folliculorum in patients receiving epidermal growth factor receptor inhibitors. |
| Q45362079 | Effectiveness of postoperative radiotherapy in patients with small oral and oropharyngeal squamous cell carcinoma and concomitant ipsilateral singular cervical lymph node metastasis (pN1) : A meta-analysis. |
| Q43447566 | Feasibility of 6-month maintenance cetuximab after adjuvant concurrent chemoradiation plus cetuximab in squamous cell carcinoma of the head and neck. |
| Q83204119 | IMRT reirradiation with concurrent cetuximab immunotherapy in recurrent head and neck cancer |
| Q43757821 | Incidence of dermatitis in head and neck cancer patients treated with primary radiotherapy and cetuximab |
| Q51127693 | Increased risk of high-grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy. |
| Q33570512 | MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer |
| Q21195817 | Management of EGFR-inhibitor associated rash: a retrospective study in 49 patients |
| Q51031797 | Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines. |
| Q38936131 | Management of radiodermatitis associated with cetuximab in squamous cell carcinomas of the head and neck |
| Q26745689 | Mechanisms underlying skin disorders induced by EGFR inhibitors |
| Q37426336 | Myofibroblastic sarcoma of the base of tongue. Case report and review of the literature |
| Q37676970 | Nuclear EGFR as novel therapeutic target: insights into nuclear translocation and function |
| Q39947637 | Ocular Ischemic Syndrome Secondary to Carotid Artery Occlusion as a Late Complication of Radiotherapy of Nasopharyngeal Carcinoma |
| Q37741005 | Osteonecrosis of the jaws: clinicopathologic and radiologic characteristics, preventive and therapeutic strategies |
| Q44840997 | Outcome and histopathologic regression in oral squamous cell carcinoma after preoperative radiochemotherapy |
| Q39744649 | Overexpression of caveolin-1 in lymphoblastoid TK6 cells enhances proliferation after irradiation with clinically relevant doses. |
| Q43266642 | Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck |
| Q26861498 | Radiotherapy and "new" drugs-new side effects? |
| Q87568566 | Severe gastrointestinal bleeding in patients with locally advanced head and neck squamous cell carcinoma treated by concurrent radiotherapy and Cetuximab |
| Q82492400 | The effects on pain and activity of daily living caused by crusted exudation in patients with head and neck cancer treated with cetuximab and radiotherapy |
| Q38979464 | The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphism |
| Q42971114 | Therapy with epidermal growth factor receptor inhibitors. Clinical spectrum of cutaneous adverse effects |
| Q53193539 | [Cutaneous side effects of targeted cancer drugs]. |
Search more.